The fusion function of enveloped viruses has been intimately tied to the initial steps in infection of susceptible host cells. In all systems studied so far the outer proteins, usually glycosylated, have been implicated in fusion. Because fusion occurs at an early point in the infectious process, blockage with either antibodies or antiviral agents has potential application to the prevention and treatment of viral diseases. The fusion function of bunyaviruses was first demonstrated in our laboratory and this proposal will explore biological and molecular aspects of fusion using California serogroup bunyaviruses. Existing data indicate that, of the two envelope glycoproteins G1 and G2, the G1 protein plays a role in fusion. However, the protein which carries the putative hydrophobic fusion sequence is yet to be determined. We propose the following studies with La Crosse and other California serogroup viruses. 1) Liposomes containing one or both viral glycoproteins will be constructed and tested for fusion capability to identify the protein responsible for fusion; 2) The M RNA gene segment coding for the viral glycoproteins will be cloned and sequenced in order to identify the region(s) of the glycoprotein that mediate fusion; 3) Fusion mutants will be generated and compared to fusion-altered antigenic mutants and to parental LAC virus to identify genome sequences associated with the fusion function; and 4) The role of fusion in infection of mice will be explored by characterizing the pathogenesis of fusion mutants that have altered neuroinvasiveness and by in vivo use of lysosomotropic agents that are though to interfere with fusion.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29AI024888-02
Application #
3454112
Study Section
Virology Study Section (VR)
Project Start
1987-07-01
Project End
1992-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Pekosz, A; Griot, C; Stillmock, K et al. (1995) Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies. J Virol 69:3475-81
Griot, C; Pekosz, A; Davidson, R et al. (1994) Replication in cultured C2C12 muscle cells correlates with the neuroinvasiveness of California serogroup bunyaviruses. Virology 201:399-403
Griot, C; Pekosz, A; Lukac, D et al. (1993) Polygenic control of neuroinvasiveness in California serogroup bunyaviruses. J Virol 67:3861-7
Griot, C; Gonzalez-Scarano, F; Nathanson, N (1993) Molecular determinants of the virulence and infectivity of California serogroup bunyaviruses. Annu Rev Microbiol 47:117-38
Jacoby, D R; Cooke, C; Prabakaran, I et al. (1993) Expression of the La Crosse M segment proteins in a recombinant vaccinia expression system mediates pH-dependent cellular fusion. Virology 193:993-6
Gonzalez-Scarano, F; Jacoby, D; Griot, C et al. (1992) Genetics, infectivity and virulence of California serogroup viruses. Virus Res 24:123-35
Chandler, L J; Hogge, G; Endres, M et al. (1991) Reassortment of La Crosse and Tahyna bunyaviruses in Aedes triseriatus mosquitoes. Virus Res 20:181-91
Endres, M J; Griot, C; Gonzalez-Scarano, F et al. (1991) Neuroattenuation of an avirulent bunyavirus variant maps to the L RNA segment. J Virol 65:5465-70
Endres, M J; Valsamakis, A; Gonzalez-Scarano, F et al. (1990) Neuroattenuated bunyavirus variant: derivation, characterization, and revertant clones. J Virol 64:1927-33
Endres, M J; Jacoby, D R; Janssen, R S et al. (1989) The large viral RNA segment of California serogroup bunyaviruses encodes the large viral protein. J Gen Virol 70 ( Pt 1):223-8

Showing the most recent 10 out of 11 publications